WO1998052514A3 - Treatment of hepatic cirrhosis - Google Patents

Treatment of hepatic cirrhosis Download PDF

Info

Publication number
WO1998052514A3
WO1998052514A3 PCT/US1998/010505 US9810505W WO9852514A3 WO 1998052514 A3 WO1998052514 A3 WO 1998052514A3 US 9810505 W US9810505 W US 9810505W WO 9852514 A3 WO9852514 A3 WO 9852514A3
Authority
WO
WIPO (PCT)
Prior art keywords
treatment
hepatic cirrhosis
composition
hepatic
cirrhosis
Prior art date
Application number
PCT/US1998/010505
Other languages
French (fr)
Other versions
WO1998052514A2 (en
Inventor
Mark Pines
Arnon Nagler
Original Assignee
Hadasit Med Res Service
Agricultural Res Org
Friedman Mark M
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25338371&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO1998052514(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hadasit Med Res Service, Agricultural Res Org, Friedman Mark M filed Critical Hadasit Med Res Service
Priority to AU76922/98A priority Critical patent/AU748754B2/en
Priority to KR1019997010803A priority patent/KR100540537B1/en
Priority to CA002290502A priority patent/CA2290502C/en
Priority to IL13284898A priority patent/IL132848A/en
Priority to EP98924847A priority patent/EP1014988A2/en
Priority to JP55068298A priority patent/JP2002515905A/en
Publication of WO1998052514A2 publication Critical patent/WO1998052514A2/en
Publication of WO1998052514A3 publication Critical patent/WO1998052514A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

A composition for treating hepatic fibrosis and hepatic cirrhosis, and methods of using and manufacturing the composition are provided. The composition includes a quinazolinone derivative, preferably Halofuginone.
PCT/US1998/010505 1997-05-23 1998-05-22 Treatment of hepatic cirrhosis WO1998052514A2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
AU76922/98A AU748754B2 (en) 1997-05-23 1998-05-22 Treatment of hepatic cirrhosis
KR1019997010803A KR100540537B1 (en) 1997-05-23 1998-05-22 Treatment of hepatic cirrhosis
CA002290502A CA2290502C (en) 1997-05-23 1998-05-22 Treatment of hepatic cirrhosis
IL13284898A IL132848A (en) 1997-05-23 1998-05-22 Composition for treating hepatic cirrhosis
EP98924847A EP1014988A2 (en) 1997-05-23 1998-05-22 Treatment of hepatic cirrhosis
JP55068298A JP2002515905A (en) 1997-05-23 1998-05-22 Treatment of cirrhosis

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86238297A 1997-05-23 1997-05-23
US08/862,382 1997-05-23

Publications (2)

Publication Number Publication Date
WO1998052514A2 WO1998052514A2 (en) 1998-11-26
WO1998052514A3 true WO1998052514A3 (en) 1999-08-19

Family

ID=25338371

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1998/010505 WO1998052514A2 (en) 1997-05-23 1998-05-22 Treatment of hepatic cirrhosis

Country Status (8)

Country Link
EP (1) EP1014988A2 (en)
JP (1) JP2002515905A (en)
KR (1) KR100540537B1 (en)
CN (1) CN1160073C (en)
AU (1) AU748754B2 (en)
CA (1) CA2290502C (en)
IL (1) IL132848A (en)
WO (1) WO1998052514A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004039308A2 (en) * 2002-10-31 2004-05-13 State Of Israel, Ministry Of Agriculture Quinazolinone compositions for regulation of gene expression related to pathological processes

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3320124A (en) * 1964-07-20 1967-05-16 American Cyanamid Co Method for treating coccidiosis with quinazolinones
US5449678A (en) * 1994-01-11 1995-09-12 Agricultural Research Organization, Ministry Of Agriculture Anti-fibrotic quinazolinone-containing compositions and methods for the use thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3320124A (en) * 1964-07-20 1967-05-16 American Cyanamid Co Method for treating coccidiosis with quinazolinones
US5449678A (en) * 1994-01-11 1995-09-12 Agricultural Research Organization, Ministry Of Agriculture Anti-fibrotic quinazolinone-containing compositions and methods for the use thereof

Also Published As

Publication number Publication date
IL132848A0 (en) 2001-03-19
KR20010012838A (en) 2001-02-26
KR100540537B1 (en) 2006-01-10
CN1160073C (en) 2004-08-04
AU7692298A (en) 1998-12-11
CA2290502A1 (en) 1998-11-26
IL132848A (en) 2004-08-31
WO1998052514A2 (en) 1998-11-26
JP2002515905A (en) 2002-05-28
EP1014988A2 (en) 2000-07-05
CN1265034A (en) 2000-08-30
AU748754B2 (en) 2002-06-13
CA2290502C (en) 2007-08-28

Similar Documents

Publication Publication Date Title
ZA997058B (en) Game machine and method of controlling the same.
AU6853598A (en) Aligner, exposure method using the aligner, and method of manufacture of circuitdevice
AU1393000A (en) 1,4-diazabicyclo(3.2.2)nonane derivatives, their preparation and therapeutic application
AU5194999A (en) Benzothiepin derivatives, process for the preparation of the same and uses thereof
ZA987540B (en) Process for the preparation of stanol esters, and use thereof.
AU2001249881A1 (en) Method of treating the heart
AU2002213273A1 (en) Stenoprophiluric matrices, and methods of making and using the same
ZA200203367B (en) Antidiabetic formulation and method.
AU7470898A (en) Methods for forming integrated circuits within substrates, and embedded circui ts
AU3763299A (en) Supramolecular structures and process for making the same
AU1392900A (en) 2,5-diazabicyclo(2.2.1)heptane derivatives, their preparation and therapeutic uses
AU7808198A (en) Novel compounds useful in the complement, coagulat and kallikrein pathways and method for their preparation
ZA200201816B (en) A vaccine composition and method of using the same.
AU2045499A (en) Cuff electrode and method for manufacturing the same
AU1262699A (en) Stage device and method of manufacturing the same, and aligner and method of manufacturing the same
AU1280100A (en) Novel 2-pyridone derivatives, preparation method and therapeutic use
AU3876399A (en) Waders and the method for manufacturing them
AU1628397A (en) Fluoroalkyl- and fluoroalkoxy-substituted heterocyclic bradykinin antagonists, process for their preparation, and their use
AU3501800A (en) Aqueous dispersion composition and manufacturing method for the composition
PL354994A1 (en) Bio-supportive matrices, methods of making and using the same
AU5057600A (en) Component and method for the production thereof
AU2002241739A1 (en) Antimycobacterial compounds and method for making the same
AU2290801A (en) Hardware token self enrollment process
WO1998052514A3 (en) Treatment of hepatic cirrhosis
AU2547399A (en) Pyridone derivatives and process for producing the same

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 132848

Country of ref document: IL

Ref document number: 98805389.6

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

ENP Entry into the national phase

Ref document number: 2290502

Country of ref document: CA

Ref document number: 2290502

Country of ref document: CA

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 1019997010803

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 76922/98

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 1998924847

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1998924847

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1019997010803

Country of ref document: KR

WWW Wipo information: withdrawn in national office

Ref document number: 1998924847

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 76922/98

Country of ref document: AU

WWW Wipo information: withdrawn in national office

Ref document number: 1019997010803

Country of ref document: KR

WWG Wipo information: grant in national office

Ref document number: 1019997010803

Country of ref document: KR